
|Videos|June 23, 2021
Dr. Ramasamy discusses clinical trial of nasal testosterone gel
Author(s)Urology Times staff
“It's quick to act and it's quick to leave the system,” says Ranjith Ramasamy, MD, of the nasal testosterone gel Natesto.
Advertisement
In this video, Ranjith Ramasamy, MD, discusses a clinical trial at his institution evaluating the nasal testosterone gel Nastesto. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Matthew Galsky, MD, on how EV/pembrolizumab is redefining the MIBC treatment paradigm
2
Published BOND-003 data show durable responses with cretostimogene in NMIBC
3
Pearls & Perspectives: From Prostate Cancer Diagnosis to Patient Advocacy, with Gabe Canales
4
Cretostimogene Grenadenorepvec: Mechanism and Rationale
5












